retatrutide triple The future of metabolic science begins here. represents a new generation of metabolic therapies by acting simultaneously on GLP-1, GIP and Glucagon receptors—a agonist designed to support multiple pathways involved First Retatrutide phase 3 data,
Pay in 4 interest-free payments of $7.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27






















